BMP2 and osteoporosis: We demonstrated that Kdm5a-mediated H3K4me3 modification participates in the etiology of osteoporosis, which may provide new strategies to improve the clinical efficacy of BMP2 and to enhance bone formation under osteoporotic conditions.